Schering Reinvesting In Sales After Cutbacks; “Selective” Support For Zetia

Schering-Plough will begin to reverse cutbacks in its primary care sales force, CEO Fred Hassan told investors during a conference call July 23

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet